BIO INX Announces the Launch of BIORES INX: A Groundbreaking Gelatin-Based DLP Resin for Bioprinting

GENT, Belgium - Dec. 2, 2024 - PRLog -- BIO INX, a leading innovator in materials for 3D bioprinting, is proud to announce the launch of BIORES INX, the latest addition to its cutting-edge portfolio of bioprinting resins. Building on decades of expertise in gelatin-based formulations, BIORES INX represents a significant breakthrough in bioprinting technology, offering unparalleled ease of use, biocompatibility, and compatibility with DLP (digital light processing) bioprinting platforms.

BIORES INX is a gelatin methacrylamide (GelMA)-based resin that capitalizes on over 25 years of GelMA expertise, originally developed at Ghent University and now perfected by BIO INX, a spin-out from the same research group. Thanks to the close resemblance of gelatin to the natural extracellular matrix, BIORES INX delivers exceptional biocompatibility while offering seamless processing. The sterile resin meets ISO 10993-5 standards for biocompatibility, underscoring its suitability for advanced biofabrication applications.

What sets BIORES INX apart is its liquid state at room temperature, a feature that eliminates the need for heated containers and prevents water evaporation during printing—common challenges associated with gelatin-based resins. As the second bioresin in BIO INX's DLP portfolio, and the 9th bioresin in BIO INX' light-based portfolio, BIORES INX reinforces BIO INX's mantra of "from light to life."

For more information, visit www.bioinx.com or meet the team at the MRS Fall Meeting in Boston.

About BIO INX:

BIO INX is a pioneering developer of materials for 3D bioprinting, committed to advancing the frontiers of healthcare through innovative solutions. As a spin-out from Ghent University and the Vrije Universiteit Brussel, BIO INX has established itself as a market leader in bioinks for high resolution bioprinting, focusing on materials for both extrusion- and light-based high-resolution printing technologies and offering a diverse portfolio of bioinks for various 3D bioprinting technologies.

Contact:

Jasper Van Hoorick
CEO, BIO INX
E : Jasper.vanhoorick@bioinx.com
T : +32 499 16 98 94
www.bioinx.com